NASDAQ:MOTS - Motus GI Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $7.59 +0.17 (+2.29 %) (As of 07/19/2018 04:00 PM ET)Previous Close$7.42Today's Range$7.41 - $7.7352-Week Range$3.75 - $10.66Volume26,383 shsAverage Volume83,224 shsMarket Capitalization$119.69 millionP/E Ratio-5.91Dividend YieldN/ABetaN/A Company ProfileAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Motus GI Holdings, Inc. operates as a medical technology company to enhance the endoscopy outcomes and experiences in the United States and Israel. It focuses on the development and commercialization of the Pure-Vu system to enhance the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company is based in Fort Lauderdale, Florida. Receive MOTS News and Ratings via Email Sign-up to receive the latest news and ratings for MOTS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolNASDAQ:MOTS CUSIPN/A Webwww.motusgi.com Phone786-459-1831 Debt Debt-to-Equity RatioN/A Current Ratio12.32 Quick Ratio12.31 Price-To-Earnings Trailing P/E Ratio-5.91 Forward P/E Ratio-6.96 P/E GrowthN/A Sales & Book Value Annual Sales$10,000.00 Price / Sales11,878.35 Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees39 Outstanding Shares15,650,000Market Cap$119.69 Motus GI (NASDAQ:MOTS) Frequently Asked Questions What is Motus GI's stock symbol? Motus GI trades on the NASDAQ under the ticker symbol "MOTS." How were Motus GI's earnings last quarter? Motus GI Holdings Inc (NASDAQ:MOTS) posted its quarterly earnings data on Tuesday, May, 15th. The company reported ($0.33) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.24) by $0.09. The company earned $0.01 million during the quarter. View Motus GI's Earnings History. What price target have analysts set for MOTS? 3 Wall Street analysts have issued 1 year price targets for Motus GI's stock. Their predictions range from $7.00 to $12.00. On average, they expect Motus GI's share price to reach $9.6667 in the next year. This suggests a possible upside of 27.4% from the stock's current price. View Analyst Ratings for Motus GI. What is the consensus analysts' recommendation for Motus GI? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Motus GI in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Who are some of Motus GI's key competitors? Some companies that are related to Motus GI include Endologix (ELGX), Neuronetics (STIM), Antares Pharma (ATRS), Inovio Pharmaceuticals (INO), GenMark Diagnostics (GNMK), Orthopediatrics (KIDS), MiMedx Group (MDXG), Utah Medical Products (UTMD), Cytosorbents (CTSO), Westaim (WEDXF), Accuray (ARAY), T2 Biosystems (TTOO), RenovaCare (RCAR), Iradimed (IRMD) and Pulse Biosciences (PLSE). Who are Motus GI's key executives? Motus GI's management team includes the folowing people: Mr. Mark Pomeranz, CEO & Director (Age 56)Mr. Andrew Lawrence Taylor, Chief Financial Officer (Age 47)Mr. Todd Van Emburgh, PresMs. Hagit Ephrath, VP Health Economics, Regulatory & Clinical AffairsGil Balog, Gen. Mang. of Israel When did Motus GI IPO? (MOTS) raised $21 million in an IPO on Wednesday, February 14th 2018. The company issued 3,500,000 shares at $5.00-$7.00 per share. Piper Jaffray served as the underwriter for the IPO and Oppenheimer & Co. was co-manager. When does the company's lock-up period expire? Motus GI's lock-up period expires on Monday, August 13th. Motus GI had issued 3,500,000 shares in its public offering on February 14th. The total size of the offering was $17,500,000 based on an initial share price of $5.00. After the end of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company. Has Motus GI been receiving favorable news coverage? News coverage about MOTS stock has trended somewhat positive on Thursday, Accern reports. The research group ranks the sentiment of media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Motus GI earned a coverage optimism score of 0.16 on Accern's scale. They also assigned news headlines about the company an impact score of 46.41 out of 100, meaning that recent media coverage is somewhat unlikely to have an effect on the company's share price in the next few days. How do I buy shares of Motus GI? Shares of MOTS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Motus GI's stock price today? One share of MOTS stock can currently be purchased for approximately $7.59. How big of a company is Motus GI? Motus GI has a market capitalization of $119.69 million and generates $10,000.00 in revenue each year. The company earns $-13,200,000.00 in net income (profit) each year or ($1.28) on an earnings per share basis. Motus GI employs 39 workers across the globe. How can I contact Motus GI? Motus GI's mailing address is 1301 EAST BROWARD BOULEVARD 3rd Floor, FT. LAUDERDALE FL, 33301. The company can be reached via phone at 786-459-1831 or via email at [email protected] MarketBeat Community Rating for Motus GI (NASDAQ MOTS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 36 (Vote Outperform)Underperform Votes: 32 (Vote Underperform)Total Votes: 68MarketBeat's community ratings are surveys of what our community members think about Motus GI and other stocks. Vote "Outperform" if you believe MOTS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MOTS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/19/2018 by MarketBeat.com StaffFeatured Article: What kind of dividend yield to CEF's pay?